Serraj Khalid, Alaoui Habiba, El Oumri Ahmed Amine, Barrimi Mohamed, Bachir Houda
Internal Medicine, Faculty of Medicine and Pharmacy, Mohammed Premier University, Oujda, MAR.
Immunohematology Cellular Therapy, Faculty of Medicine and Pharmacy, Mohammed Premier University, Oujda, MAR.
Cureus. 2020 Oct 23;12(10):e11101. doi: 10.7759/cureus.11101.
The diagnostic management of systemic granulomatosis is a difficult clinical exercise. The most frequent etiologies are tuberculosis and sarcoidosis. However, it is important to search as well for the other causes of granulomas, especially infections and malignancies, the prognosis of which can be poor without adequate treatment. A 67-year-old immunocompetent patient presented with granulomatous adenitis without caseous necrosis. The etiological evaluation had revealed neurological, pulmonary and lymph node systemic cryptococcosis. Conventional antifungal therapy with the triple combination Amphotericin B - Flucytosine - Fluconazole has not been effective, indicating administration of voriconazole. The evolution was rapidly favorable with apyrexia after 48 hours, disappearance of clinical symptoms, normalization of biological parameters of cerebrospinal fluid (CSF) and major improvement of radiological abnormalities. This clinical case is original by the disseminated involvement, the patient's non-immunocompromised status and the primary resistance to amphotericin B. Our findings underline the importance of carrying out an exhaustive evaluation, reflecting on cryptococcosis in any systemic granulomatosis and knowing the various therapeutic alternatives, in particular, voriconazole if primary response to amphotericin B has not been obtained.
系统性肉芽肿病的诊断管理是一项困难的临床工作。最常见的病因是结核病和结节病。然而,同样重要的是要查找肉芽肿的其他病因,尤其是感染和恶性肿瘤,如果不进行充分治疗,其预后可能很差。一名67岁免疫功能正常的患者出现了无干酪样坏死的肉芽肿性腺炎。病因评估显示为神经、肺和淋巴结系统性隐球菌病。两性霉素B-氟胞嘧啶-氟康唑三联常规抗真菌治疗无效,表明需使用伏立康唑。治疗后病情迅速好转,48小时后退热,临床症状消失,脑脊液(CSF)生物学参数恢复正常,影像学异常明显改善。该临床病例的独特之处在于病变广泛播散、患者免疫功能正常以及对两性霉素B原发耐药。我们的研究结果强调了进行详尽评估的重要性,对于任何系统性肉芽肿病都要考虑到隐球菌病,并了解各种治疗选择,特别是在对两性霉素B未获得初始反应时使用伏立康唑。